597 related articles for article (PubMed ID: 33391523)
1. IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression.
Zhang L; Wan Y; Zhang Z; Jiang Y; Gu Z; Ma X; Nie S; Yang J; Lang J; Cheng W; Zhu L
Theranostics; 2021; 11(3):1100-1114. PubMed ID: 33391523
[No Abstract] [Full Text] [Related]
2. IGF2BP1 enhances the stability of SIK2 mRNA through m
Xu Y; Xu L; Kong Y; Li K; Li J; Xu F; Liang S; Chen B
Biochem Biophys Res Commun; 2023 Dec; 684():149113. PubMed ID: 37866243
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressive function of IGF2BP1 in gastric cancer through decreasing MYC.
Ding N; Cao G; Wang Z; Xu S; Chen W
Cancer Sci; 2024 Feb; 115(2):427-438. PubMed ID: 38115228
[TBL] [Abstract][Full Text] [Related]
4. LncRNA linc01194 promotes the progress of endometrial carcinoma by up-regulating SOX2 through binding to IGF2BP1.
Huang Z; Shen F; Chen J; Xie B; Chen X; Zhao Y; Chen S
J Gynecol Oncol; 2024 Mar; 35(2):e21. PubMed ID: 38072399
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA linc00659 promotes tumour progression by regulating FZD6/Wnt/β-catenin signalling pathway in colorectal cancer via m6A reader IGF2BP1.
Xu S; Liu Z; Luo Q; Chang L; Ding J; Xiao Y; Zhang Y; Zhou G; Wang K
J Gene Med; 2024 Jan; 26(1):e3636. PubMed ID: 38009760
[TBL] [Abstract][Full Text] [Related]
6. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
[TBL] [Abstract][Full Text] [Related]
7. The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer.
Müller S; Bley N; Busch B; Glaß M; Lederer M; Misiak C; Fuchs T; Wedler A; Haase J; Bertoldo JB; Michl P; Hüttelmaier S
Nucleic Acids Res; 2020 Sep; 48(15):8576-8590. PubMed ID: 32761127
[TBL] [Abstract][Full Text] [Related]
8. A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability.
Zhu P; He F; Hou Y; Tu G; Li Q; Jin T; Zeng H; Qin Y; Wan X; Qiao Y; Qiu Y; Teng Y; Liu M
Oncogene; 2021 Mar; 40(9):1609-1627. PubMed ID: 33469161
[TBL] [Abstract][Full Text] [Related]
9. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B
J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738
[TBL] [Abstract][Full Text] [Related]
10. IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner.
Müller S; Glaß M; Singh AK; Haase J; Bley N; Fuchs T; Lederer M; Dahl A; Huang H; Chen J; Posern G; Hüttelmaier S
Nucleic Acids Res; 2019 Jan; 47(1):375-390. PubMed ID: 30371874
[TBL] [Abstract][Full Text] [Related]
11. CircPTPRA blocks the recognition of RNA N
Xie F; Huang C; Liu F; Zhang H; Xiao X; Sun J; Zhang X; Jiang G
Mol Cancer; 2021 Apr; 20(1):68. PubMed ID: 33853613
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor 2 mRNA-binding protein 1 promotes cell proliferation
Wan BS; Cheng M; Zhang L
World J Gastroenterol; 2019 Oct; 25(40):6063-6076. PubMed ID: 31686763
[TBL] [Abstract][Full Text] [Related]
13. HNRNPA2B1-mediated m6A modification of FOXM1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of LCN2.
Jiang J; Zhu J; Qiu P; Ni J; Zhu W; Wang X
Funct Integr Genomics; 2023 Dec; 24(1):3. PubMed ID: 38091112
[TBL] [Abstract][Full Text] [Related]
14. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
[TBL] [Abstract][Full Text] [Related]
15. NORAD orchestrates endometrial cancer progression by sequestering FUBP1 nuclear localization to promote cell apoptosis.
Han T; Wu Y; Hu X; Chen Y; Jia W; He Q; Bian Y; Wang M; Guo X; Kang J; Wan X
Cell Death Dis; 2020 Jun; 11(6):473. PubMed ID: 32555178
[TBL] [Abstract][Full Text] [Related]
16. Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer.
Ma J; Yang D; Ma XX
Aging (Albany NY); 2021 Jun; 13(12):16287-16315. PubMed ID: 34230220
[TBL] [Abstract][Full Text] [Related]
17. m
Ruan P; Wang S; Yang C; Huang X; Sun P; Tan A
Cell Biol Toxicol; 2023 Aug; 39(4):1611-1626. PubMed ID: 35971034
[TBL] [Abstract][Full Text] [Related]
18. IGF2BP1-mediated N6-methyladenosine modification promotes intrahepatic cholangiocarcinoma progression.
Xiao P; Meng Q; Liu Q; Lang Q; Yin Z; Li G; Li Z; Xu Y; Yu Z; Geng Q; Zhang Y; Liu L; Xie Y; Li L; Chen H; Pei T; Sun B
Cancer Lett; 2023 Mar; 557():216075. PubMed ID: 36736530
[TBL] [Abstract][Full Text] [Related]
19.
Yang Y; Wu J; Liu F; He J; Wu F; Chen J; Jiang Z
Stem Cells Dev; 2021 Nov; 30(22):1115-1125. PubMed ID: 34514861
[TBL] [Abstract][Full Text] [Related]
20. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
